Items where authors include "Ford, A.C."

Article

Khasawneh, M., Shaikh, F.A., Ng, C.E. et al. (3 more authors) (2024) Utility of irritable bowel syndrome subtypes and most troublesome symptom in predicting disease impact and burden. Neurogastroenterology & Motility. e14756. ISSN 1350-1925

Goodoory, V.C. orcid.org/0000-0001-9483-5604, Tuteja, A.K., Black, C.J. et al. (1 more author) (2024) Systematic Review and Meta-analysis: Efficacy of Mesalamine in Irritable Bowel Syndrome. Clinical Gastroenterology and Hepatology, 22 (2). E5. pp. 243-251. ISSN 1542-3565

Barberio, B., Gracie, D.J., Black, C.J. et al. (1 more author) (2024) Maintenance of clinical remission with biologics and small molecules in inflammatory bowel disease according to trial design: Meta-analysis. Digestive and Liver Disease, 56 (1). pp. 7-14. ISSN 1590-8658

Khasawneh, M., Craig, O.F., Gracie, D.J. et al. (2 more authors) (2023) A Diagnosis of Irritable Bowel Syndrome Using Rome IV Criteria and Limited Investigations is Durable in Secondary Care. Clinical Gastroenterology and Hepatology, 21 (13). pp. 3397-3404. ISSN 1542-3565

Goodoory, V.C., Khasawneh, M., Black, C.J. et al. (3 more authors) (2023) Efficacy of Probiotics in Irritable Bowel Syndrome: Systematic Review and Meta-analysis. Gastroenterology, 165 (5). pp. 1206-1218. ISSN 0016-5085

Riggott, C., Fairbrass, K.M., Selinger, C.P. et al. (2 more authors) (2023) Impact of Opioid Use on the Natural History of Inflammatory Bowel Disease: Prospective Longitudinal Follow-up Study. Inflammatory Bowel Diseases. ISSN 1078-0998

Ford, A.C., Wright-Hughes, A., Alderson, S.L. et al. (65 more authors) (2023) Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet. ISSN 0140-6736

Visaggi, P. orcid.org/0000-0002-6985-5301, Barberio, B., Del Corso, G. et al. (4 more authors) (2023) Comparison of drugs for active eosinophilic oesophagitis: systematic review and network meta-analysis. Gut, 72 (11). pp. 2019-2030. ISSN 0017-5749

Riggott, C. orcid.org/0000-0002-6927-9498, Fairbrass, K.M. orcid.org/0000-0002-5569-4762, Black, C.J. orcid.org/0000-0001-5449-3603 et al. (2 more authors) (2023) Novel symptom clusters predict disease impact and healthcare utilisation in inflammatory bowel disease: Prospective longitudinal follow-up study. Alimentary Pharmacology & Therapeutics. ISSN 0269-2813

Riggott, C., Mikocka-Walus, A., Gracie, D.J. et al. (1 more author) (2023) Efficacy of psychological therapies in people with inflammatory bowel disease: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology, 8 (10). pp. 919-931. ISSN 2468-1253

Chuah, K. orcid.org/0000-0001-9811-7546, Black, C.J. orcid.org/0000-0001-5449-3603, Tee, V. orcid.org/0000-0002-6562-2666 et al. (6 more authors) (2023) A prospective comparison of UK and Malaysian patients with irritable bowel syndrome in secondary care. Alimentary Pharmacology and Therapeutics, 58 (2). pp. 168-174. ISSN 0269-2813

Goodoory, V.C. and Ford, A.C. orcid.org/0000-0001-6371-4359 (2023) Antibiotics and Probiotics for Irritable Bowel Syndrome. Drugs, 83 (8). pp. 687-699. ISSN 0012-6667

Jaafari, H., Houghton, L.A. orcid.org/0000-0002-5351-0229, West, R.M. et al. (13 more authors) (2023) The national prevalence of disorders of gut brain interaction in the United Kingdom in comparison to their worldwide prevalence: results from the Rome foundation global epidemiology study. Neurogastroenterology & Motility. ISSN 1350-1925

Black, C.J., Paine, P.A., Agrawal, A. et al. (10 more authors) (2022) British Society of Gastroenterology guidelines on the management of functional dyspepsia. Gut, 71 (9). pp. 1697-1723. ISSN 0017-5749

Rej, A., Avery, A., Ford, A.C. et al. (8 more authors) (2018) Clinical application of dietary therapies in Irritable Bowel Syndrome. Journal of Gastrointestinal and Liver Diseases, 27 (3). pp. 307-316. ISSN 1841-8724